When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks and ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...

Obesity is a major public health and economic challenge in the US, costing the health care system an estimated $173 billion ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide mimic endogenous incretin signals to stimulate glucose-dependent insulin release, thereby suppressing glucagon, ...

There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names ...

Obesity treatment is hurtling into a new era: once-a-week GLP-1 injections are edging toward the dramatic results of bariatric surgery, yet many of us remain tethered to the very habits that fuel ...

The GLP-1 food market is booming, with global value hitting $53bn and major brands like Nestlé and General Mills launching ...

Over a dozen phase 3 trials for generic semaglutide are underway in China, setting the stage for one of the world’s largest generic launches.

She used various methods of birth control — the pill, and then an intrauterine device (IUD) for 10 years. Her periods had been irregular since she was a teenager, but she wasn’t diagnosed with ...

This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.